A South Florida company secures new investment
South Florida’s innovation ecosystem extends beyond software, artificial intelligence and financial technology.
Companies developing healthcare products, medical technologies and specialized consumer solutions are also attracting investment.
Hollywood, Florida-based BeeCure is one example.
On November 16, 2026, Refresh Miami reported that SanMelix Laboratories, the parent company of BeeCure, had closed a $1 million pre-seed financing round.
Capital Q Ventures participated as the final investor in the round.
The financing will support the company’s efforts to expand commercialization of its specialized skin and wound-care products.
What does BeeCure develop?
BeeCure focuses on specialized skincare and wound-care products using proprietary buckwheat honey-based formulations.
Honey has a history of use in wound-care research and certain medical products.
However, different honey formulations can vary significantly in composition, processing, safety and intended use.
The effectiveness of a particular product depends on its formulation and the clinical evidence supporting its intended application.
BeeCure’s financing announcement describes its commercial product strategy but does not provide sufficient independent clinical evidence to establish that its products outperform standard wound-care treatments.
Consumers and healthcare professionals should evaluate individual products based on their regulatory status, instructions and supporting evidence.
Funding the commercialization process
The $1 million pre-seed financing is intended to help SanMelix Laboratories expand its commercial operations.
According to the announcement summarized by Refresh Miami, planned priorities include sales and distribution, marketing, product development and operational resources.
The company also expects to pursue additional business partnerships and commercial opportunities.
These are planned uses of capital rather than confirmation that new distribution agreements or sales milestones have already been achieved.
For a young healthcare-related business, commercialization can involve multiple challenges.
Companies must develop reliable products, establish manufacturing and quality processes, reach customers and navigate applicable regulatory requirements.
Investment can help support these activities, but it does not guarantee commercial success.
The role of Capital Q Ventures
Capital Q Ventures participated in the financing and is expected to provide business support alongside investment capital.
Its model includes assistance with strategic planning, business development and commercialization.
That approach reflects a broader trend in early-stage investing.
Startups often need operational guidance as much as financial resources, particularly when bringing specialized products into competitive markets.
For companies working in healthcare-related categories, commercial expertise can be especially important because product claims, distribution requirements and customer expectations may differ from those in conventional consumer markets.
Leadership and company growth
BeeCure is led by CEO Steve Weinstein, who discussed the financing and the company’s plans to expand commercialization.
The available reporting does not establish that BeeCure or SanMelix Laboratories is woman-founded.
For that reason, this article does not characterize the company as a women-led startup.
Its relevance to Fems in STEM lies in its South Florida entrepreneurship story and the broader intersection of product development, health-related innovation and commercialization.
Opportunities in health-related entrepreneurship
Developing and commercializing specialized skincare and wound-care products can require expertise across several disciplines.
Depending on the product and regulatory category, relevant fields may include chemistry, materials science, formulation development, quality assurance, manufacturing and regulatory affairs.
Businesses also need professionals in marketing, distribution, customer education, partnerships and operations.
For women interested in STEM entrepreneurship, these functions illustrate the range of skills required to move a product from development into the marketplace.
Not every innovation business begins with software or a major laboratory breakthrough.
Some focus on improving specialized products, developing new formulations or serving overlooked customer needs.
What comes next?
SanMelix Laboratories plans to use the financing to strengthen BeeCure’s commercial operations and expand its market reach.
The next meaningful milestones will involve execution: product development, distribution, customer adoption and evidence supporting product performance.
The company has not disclosed enough information in the reviewed announcement to establish revenue, profitability or specific clinical outcomes.
Nevertheless, the financing highlights continued investment activity in Broward County.
For the South Florida startup ecosystem, BeeCure is another example of a company pursuing growth in a specialized market outside the region’s better-known technology sectors.
Sources and further reading
– Refresh Miami — BeeCure financing coverage, November 16, 2026
Looking for Your Next Opportunity in STEM?
Explore Fems in STEM Career Connections for career opportunities, entrepreneurship resources and emerging technology developments.
Subscribe to Fems in STEM Career Connections for curated updates.
This article is independent editorial coverage based on publicly available information. It is not sponsored by or affiliated with the organizations mentioned. No claim of superior clinical effectiveness or specific regulatory approval is made for the products described.
Discover more from Fems in STEM
Subscribe to get the latest posts sent to your email.
